SweetValueLab
Write for us

Colgate-Palmolive Company — Wall Street Analyst Estimates & Price Targets

CL
NYSEConsumer DefensiveHousehold & Personal ProductsCIK 0000021665colgatepalmolive.comAbout CL
Last close · Oct 16, 202694.11+1.44 (+1.55%)
Market cap$75.0B

5 firms' latest targets, last 90 days: median $104.00 ($95.00–$106.00), 11% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$80.0$90.0$100$110NovJan 2026MarMayJulSep2025-11-03 · Evercore ISI: $94.02025-11-03 · Morgan Stanley: $87.02025-12-09 · RBC Capital: $88.02025-12-16 · Jefferies: $85.02026-01-06 · Piper Sandler: $88.02026-01-13 · Wells Fargo: $86.02026-01-14 · UBS: $93.02026-01-16 · Barclays: $83.02026-01-30 · Piper Sandler: $96.02026-01-31 · Goldman Sachs: $94.02026-02-01 · Wells Fargo: $94.02026-02-02 · Morgan Stanley: $1002026-02-03 · Barclays: $88.02026-02-13 · Rothschild & Co Redburn: $93.02026-02-20 · Goldman Sachs: $1002026-04-08 · Piper Sandler: $92.02026-04-08 · Wells Fargo: $92.02026-04-09 · RBC Capital: $1022026-04-14 · Barclays: $79.02026-04-21 · Rothschild & Co Redburn: $1002026-05-04 · UBS: $1002026-05-04 · Deutsche Bank: $99.02026-06-11 · Bernstein: $96.02026-07-08 · Wells Fargo: $95.02026-08-03 · RBC Capital: $1042026-08-03 · Deutsche Bank: $1012026-08-03 · Morgan Stanley: $1042026-08-03 · UBS: $1092026-09-21 · Piper Sandler: $95.02026-10-15 · UBS: $106
$80.0$90.0$100$110NovFebMayAug

Each firm's latest target

last 90 days · 5 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-15UBS$106.00$109.00▼ 3%+13%+13%
2026-09-21Piper Sandler$95.00$92.00▲ 3%+9%+1%
2026-08-03RBC Capital$104.00$102.00▲ 2%+13%+11%
2026-08-03Deutsche Bank$101.00$99.00▲ 2%+11%+7%
2026-08-03Morgan Stanley$104.00$100.00▲ 4%+13%+11%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$19.5B+8%$2.77+30%est. $19.4B+0%est. $3.1911
2024reported$20.1B+3%$3.51+27%est. $20.1B+0%est. $3.5713
2025reported$20.4B+1%$2.63-25%est. $20.3B+0%est. $3.6513
2026$21.4B+5%$3.86+6%$21.1B–$21.6B$3.82–$4.0114
2027$22.1B+3%$4.09+6%$21.7B–$22.4B$4.02–$4.1815
2028$22.9B+4%$4.40+8%$22.4B–$23.5B$3.62–$4.7113
2029$23.5B+3%$4.61+5%$23.1B–$23.8B$4.50–$4.6811
2030$24.2B+3%$4.79+4%$23.7B–$24.5B$4.68–$4.876
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.